| Date Filed | Type | Description |
| 02/13/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 11.3% stake in Meridian Bioscience Inc. |
| 02/09/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 02/06/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/06/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/06/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/03/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/02/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 02/02/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/31/2023 |
SC 13G/A
| ROYCE & ASSOCIATES LP reports a 0.4% stake in Meridian Bioscience, Inc. |
| 01/31/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/27/2023 |
10-K/A
| Annual Report for the period ended September 30, 2022 [amend] |
| 01/20/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/10/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/12/2022 |
8-K
| Quarterly results |
| 12/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/22/2022 |
10-K
| Annual Report for the period ended September 30, 2022 |
| 11/22/2022 |
8-K
| Quarterly results |
| 11/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|